IBDEI30E ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,48054,0)
;;=E86.0^^185^2417^4
;;^UTILITY(U,$J,358.3,48054,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48054,1,3,0)
;;=3^Dehydration
;;^UTILITY(U,$J,358.3,48054,1,4,0)
;;=4^E86.0
;;^UTILITY(U,$J,358.3,48054,2)
;;=^332743
;;^UTILITY(U,$J,358.3,48055,0)
;;=Z86.31^^185^2417^100
;;^UTILITY(U,$J,358.3,48055,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48055,1,3,0)
;;=3^Personal Hx of Diabetic Foot Ulcer
;;^UTILITY(U,$J,358.3,48055,1,4,0)
;;=4^Z86.31
;;^UTILITY(U,$J,358.3,48055,2)
;;=^5063467
;;^UTILITY(U,$J,358.3,48056,0)
;;=E10.8^^185^2417^5
;;^UTILITY(U,$J,358.3,48056,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48056,1,3,0)
;;=3^Diabetes Type 1 w/ Unspec Complications
;;^UTILITY(U,$J,358.3,48056,1,4,0)
;;=4^E10.8
;;^UTILITY(U,$J,358.3,48056,2)
;;=^5002625
;;^UTILITY(U,$J,358.3,48057,0)
;;=E10.9^^185^2417^6
;;^UTILITY(U,$J,358.3,48057,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48057,1,3,0)
;;=3^Diabetes Type 1 w/o Complications
;;^UTILITY(U,$J,358.3,48057,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,48057,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,48058,0)
;;=E11.40^^185^2417^15
;;^UTILITY(U,$J,358.3,48058,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48058,1,3,0)
;;=3^Diabetes Type 2 w/ Diabetic Neuropathy,Unspec
;;^UTILITY(U,$J,358.3,48058,1,4,0)
;;=4^E11.40
;;^UTILITY(U,$J,358.3,48058,2)
;;=^5002644
;;^UTILITY(U,$J,358.3,48059,0)
;;=E11.620^^185^2417^11
;;^UTILITY(U,$J,358.3,48059,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48059,1,3,0)
;;=3^Diabetes Type 2 w/ Diabetic Dermatitis
;;^UTILITY(U,$J,358.3,48059,1,4,0)
;;=4^E11.620
;;^UTILITY(U,$J,358.3,48059,2)
;;=^5002655
;;^UTILITY(U,$J,358.3,48060,0)
;;=E11.610^^185^2417^14
;;^UTILITY(U,$J,358.3,48060,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48060,1,3,0)
;;=3^Diabetes Type 2 w/ Diabetic Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,48060,1,4,0)
;;=4^E11.610
;;^UTILITY(U,$J,358.3,48060,2)
;;=^5002653
;;^UTILITY(U,$J,358.3,48061,0)
;;=E11.52^^185^2417^17
;;^UTILITY(U,$J,358.3,48061,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48061,1,3,0)
;;=3^Diabetes Type 2 w/ Diabetic Periph Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,48061,1,4,0)
;;=4^E11.52
;;^UTILITY(U,$J,358.3,48061,2)
;;=^5002651
;;^UTILITY(U,$J,358.3,48062,0)
;;=E11.51^^185^2417^18
;;^UTILITY(U,$J,358.3,48062,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48062,1,3,0)
;;=3^Diabetes Type 2 w/ Diabetic Periph Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,48062,1,4,0)
;;=4^E11.51
;;^UTILITY(U,$J,358.3,48062,2)
;;=^5002650
;;^UTILITY(U,$J,358.3,48063,0)
;;=E11.621^^185^2417^19
;;^UTILITY(U,$J,358.3,48063,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48063,1,3,0)
;;=3^Diabetes Type 2 w/ Foot Ulcer
;;^UTILITY(U,$J,358.3,48063,1,4,0)
;;=4^E11.621
;;^UTILITY(U,$J,358.3,48063,2)
;;=^5002656
;;^UTILITY(U,$J,358.3,48064,0)
;;=E11.44^^185^2417^8
;;^UTILITY(U,$J,358.3,48064,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48064,1,3,0)
;;=3^Diabetes Type 2 w/ Diabetic Amyotrophy
;;^UTILITY(U,$J,358.3,48064,1,4,0)
;;=4^E11.44
;;^UTILITY(U,$J,358.3,48064,2)
;;=^5002648
;;^UTILITY(U,$J,358.3,48065,0)
;;=E11.59^^185^2417^7
;;^UTILITY(U,$J,358.3,48065,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48065,1,3,0)
;;=3^Diabetes Type 2 w/ Circulatory Complications
;;^UTILITY(U,$J,358.3,48065,1,4,0)
;;=4^E11.59
;;^UTILITY(U,$J,358.3,48065,2)
;;=^5002652
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI30E 3788 printed Nov 22, 2024@17:49:30 Page 2
IBDEI30E ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,48054,0)
+2 ;;=E86.0^^185^2417^4
+3 ;;^UTILITY(U,$J,358.3,48054,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,48054,1,3,0)
+6 ;;=3^Dehydration
+7 ;;^UTILITY(U,$J,358.3,48054,1,4,0)
+8 ;;=4^E86.0
+9 ;;^UTILITY(U,$J,358.3,48054,2)
+10 ;;=^332743
+11 ;;^UTILITY(U,$J,358.3,48055,0)
+12 ;;=Z86.31^^185^2417^100
+13 ;;^UTILITY(U,$J,358.3,48055,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,48055,1,3,0)
+16 ;;=3^Personal Hx of Diabetic Foot Ulcer
+17 ;;^UTILITY(U,$J,358.3,48055,1,4,0)
+18 ;;=4^Z86.31
+19 ;;^UTILITY(U,$J,358.3,48055,2)
+20 ;;=^5063467
+21 ;;^UTILITY(U,$J,358.3,48056,0)
+22 ;;=E10.8^^185^2417^5
+23 ;;^UTILITY(U,$J,358.3,48056,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,48056,1,3,0)
+26 ;;=3^Diabetes Type 1 w/ Unspec Complications
+27 ;;^UTILITY(U,$J,358.3,48056,1,4,0)
+28 ;;=4^E10.8
+29 ;;^UTILITY(U,$J,358.3,48056,2)
+30 ;;=^5002625
+31 ;;^UTILITY(U,$J,358.3,48057,0)
+32 ;;=E10.9^^185^2417^6
+33 ;;^UTILITY(U,$J,358.3,48057,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,48057,1,3,0)
+36 ;;=3^Diabetes Type 1 w/o Complications
+37 ;;^UTILITY(U,$J,358.3,48057,1,4,0)
+38 ;;=4^E10.9
+39 ;;^UTILITY(U,$J,358.3,48057,2)
+40 ;;=^5002626
+41 ;;^UTILITY(U,$J,358.3,48058,0)
+42 ;;=E11.40^^185^2417^15
+43 ;;^UTILITY(U,$J,358.3,48058,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,48058,1,3,0)
+46 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathy,Unspec
+47 ;;^UTILITY(U,$J,358.3,48058,1,4,0)
+48 ;;=4^E11.40
+49 ;;^UTILITY(U,$J,358.3,48058,2)
+50 ;;=^5002644
+51 ;;^UTILITY(U,$J,358.3,48059,0)
+52 ;;=E11.620^^185^2417^11
+53 ;;^UTILITY(U,$J,358.3,48059,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,48059,1,3,0)
+56 ;;=3^Diabetes Type 2 w/ Diabetic Dermatitis
+57 ;;^UTILITY(U,$J,358.3,48059,1,4,0)
+58 ;;=4^E11.620
+59 ;;^UTILITY(U,$J,358.3,48059,2)
+60 ;;=^5002655
+61 ;;^UTILITY(U,$J,358.3,48060,0)
+62 ;;=E11.610^^185^2417^14
+63 ;;^UTILITY(U,$J,358.3,48060,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,48060,1,3,0)
+66 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathic Arthropathy
+67 ;;^UTILITY(U,$J,358.3,48060,1,4,0)
+68 ;;=4^E11.610
+69 ;;^UTILITY(U,$J,358.3,48060,2)
+70 ;;=^5002653
+71 ;;^UTILITY(U,$J,358.3,48061,0)
+72 ;;=E11.52^^185^2417^17
+73 ;;^UTILITY(U,$J,358.3,48061,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,48061,1,3,0)
+76 ;;=3^Diabetes Type 2 w/ Diabetic Periph Angiopathy w/ Gangrene
+77 ;;^UTILITY(U,$J,358.3,48061,1,4,0)
+78 ;;=4^E11.52
+79 ;;^UTILITY(U,$J,358.3,48061,2)
+80 ;;=^5002651
+81 ;;^UTILITY(U,$J,358.3,48062,0)
+82 ;;=E11.51^^185^2417^18
+83 ;;^UTILITY(U,$J,358.3,48062,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,48062,1,3,0)
+86 ;;=3^Diabetes Type 2 w/ Diabetic Periph Angiopathy w/o Gangrene
+87 ;;^UTILITY(U,$J,358.3,48062,1,4,0)
+88 ;;=4^E11.51
+89 ;;^UTILITY(U,$J,358.3,48062,2)
+90 ;;=^5002650
+91 ;;^UTILITY(U,$J,358.3,48063,0)
+92 ;;=E11.621^^185^2417^19
+93 ;;^UTILITY(U,$J,358.3,48063,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,48063,1,3,0)
+96 ;;=3^Diabetes Type 2 w/ Foot Ulcer
+97 ;;^UTILITY(U,$J,358.3,48063,1,4,0)
+98 ;;=4^E11.621
+99 ;;^UTILITY(U,$J,358.3,48063,2)
+100 ;;=^5002656
+101 ;;^UTILITY(U,$J,358.3,48064,0)
+102 ;;=E11.44^^185^2417^8
+103 ;;^UTILITY(U,$J,358.3,48064,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,48064,1,3,0)
+106 ;;=3^Diabetes Type 2 w/ Diabetic Amyotrophy
+107 ;;^UTILITY(U,$J,358.3,48064,1,4,0)
+108 ;;=4^E11.44
+109 ;;^UTILITY(U,$J,358.3,48064,2)
+110 ;;=^5002648
+111 ;;^UTILITY(U,$J,358.3,48065,0)
+112 ;;=E11.59^^185^2417^7
+113 ;;^UTILITY(U,$J,358.3,48065,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,48065,1,3,0)
+116 ;;=3^Diabetes Type 2 w/ Circulatory Complications
+117 ;;^UTILITY(U,$J,358.3,48065,1,4,0)
+118 ;;=4^E11.59
+119 ;;^UTILITY(U,$J,358.3,48065,2)
+120 ;;=^5002652
